Breast cancer risk and clinical implications for germline PTEN mutation carriers Joanne NgeowKaitlin SesockCharis Eng Review 23 December 2015 Pages: 1 - 8
The Canadian National Breast Screening Studies are compromised and their results are unreliable. They should not factor into decisions about breast cancer screening Daniel B. Kopans Review 20 May 2017 Pages: 9 - 15
Influence of comorbidity on chemotherapy use for early breast cancer: systematic review and meta-analysis Melissa J. EdwardsIan D. CampbellMarion J. Kuper-Hommel Review 20 May 2017 Pages: 17 - 39
Combination breast cancer chemotherapy with doxorubicin and cyclophosphamide damages bone and bone marrow in a female rat model Chiaming FanKristen R. GeorgiouCory J. Xian Preclinical study 26 May 2017 Pages: 41 - 51
Host genetic modifiers of nonproductive angiogenesis inhibit breast cancer Michael J. FlisterShirng-Wern TsaihAmit Joshi Preclinical study 31 May 2017 Pages: 53 - 64
The 21-gene recurrence score in special histologic subtypes of breast cancer with favorable prognosis Gulisa TurashviliEdi BrogiHannah Y. Wen Preclinical study 03 June 2017 Pages: 65 - 76
Sexual health needs and educational intervention preferences for women with cancer Cara StabileShari GoldfarbJeanne Carter Clinical trial 25 May 2017 Pages: 77 - 84
Primary tumor location predicts the site of local relapse after nipple–areola complex (NAC) sparing mastectomy Nicoletta Tomasi ContFurio MaggiorottoRiccardo Ponzone Clinical Trial 28 May 2017 Pages: 85 - 95
A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen Cynthia A. ThomsonH. H. Sherry ChowPatricia A. Thompson Clinical trial 30 May 2017 Pages: 97 - 107
Identifying long-term survivors among metastatic breast cancer patients undergoing primary tumor surgery Tae-Kyung YooByung Joo ChaeByung Joo Song Clinical trial 01 June 2017 Pages: 109 - 118
Unenhanced magnetic resonance screening using fused diffusion-weighted imaging and maximum-intensity projection in patients with a personal history of breast cancer: role of fused DWI for postoperative screening Ji Won KangHee Jung ShinHak Hee Kim Clinical trial 02 June 2017 Pages: 119 - 128
Receptor activator of nuclear factor kappa B (RANK) expression in primary breast cancer correlates with recurrence-free survival and development of bone metastases in I-SPY1 (CALGB 150007/150012; ACRIN 6657) Neelima VidulaChristina YauHope S. Rugo Clinical trial 02 June 2017 Pages: 129 - 138
First international consensus conference on standardization of oncoplastic breast conserving surgery Walter P. WeberSavas D. SoysalChristian Kurzeder Clinical trial 03 June 2017 Pages: 139 - 149
Fertility preservation with ovarian stimulation and time to treatment in women with stage II–III breast cancer receiving neoadjuvant therapy A. Jo ChienJulia ChambersMitchell P. Rosen Epidemiology 13 May 2017 Pages: 151 - 159
Erratum to: Fertility preservation with ovarian stimulation and time to treatment in women with stage II–III breast cancer receiving neoadjuvant therapy A. Jo ChienJulia ChambersMitchell P. Rosen Erratum 28 June 2017 Pages: 161 - 161
Influence of clinical, societal, and treatment variables on racial differences in ER−/PR− breast cancer survival M. E. RoselandK. SchwartzMichael S. Simon Epidemiology 25 May 2017 Pages: 163 - 168
Social well-being is associated with less pro-inflammatory and pro-metastatic leukocyte gene expression in women after surgery for breast cancer Devika R. JutagirBonnie B. BlombergMichael H. Antoni Epidemiology 30 May 2017 Pages: 169 - 180
Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657) Jeffrey I. CampbellChristina YauYunn-Yi Chen Epidemiology 02 June 2017 Pages: 181 - 191
Family history and risk of breast cancer: an analysis accounting for family structure Hannah R. BrewerMichael E. JonesAnthony J. Swerdlow Epidemiology Open access 03 June 2017 Pages: 193 - 200
Lifetime moderate-to-vigorous physical activity and ER/PR/HER-defined post-menopausal breast cancer risk Joy ShiLindsay C. KobayashiKristan J. Aronson Epidemiology 06 June 2017 Pages: 201 - 213
Extensions of the Rosner-Colditz breast cancer prediction model to include older women and type-specific predicted risk Robert J. GlynnGraham A. ColditzBernard Rosner Epidemiology 06 June 2017 Pages: 215 - 223
